ABT
Abbott LaboratoriesPrevious close
106.20
Change
+1.63 / +1.56%
Market Cap
$184B
1M
+7.46%
S&P 500 −0.91% over same period
Volume / Avg Volume
8.4M / 10.3M
0.82× average
Latest earnings analysisFY2026 Q2Reported 2026-07-16
Abbott Q2 2026: sales up 13.0%, adjusted EPS $1.31, guidance raised
Abbott's 13.0% reported sales growth is mostly the Exact Sciences deal, not the base business — comparable growth was 4.8%. Adjusted EPS of $1.31 squeaked past the $1.2922 consensus, and management raised the full-year adjusted EPS range to $5.45–$5.60. The catch: getting from 4.8% to the guided 6.5%–7.5% comparable growth needs a much stronger second half.
Read the full analysis →Revenue$12.59BYoY +13.00%
EPS (non-GAAP)$1.31Beatest. $1.29
Next-day move+1.87%
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | Analysis |
|---|---|---|---|
| FY2026 Q2 Quarter ended 2026-06 | 2026-07-16 | $12.6B | Read analysis → |
| FY2026 Q1 Quarter ended 2026-03 | 2026-04-16 | $11.2B | Pending |
| FY2025 Q4 Quarter ended 2025-12 | 2026-01-22 | $44.3B | Pending |
| FY2025 Q3 Quarter ended 2025-09 | 2025-10-15 | $11.4B | Pending |
| FY2025 Q2 Quarter ended 2025-06 | 2025-07-17 | $11.1B | Pending |
| FY2025 Q1 Quarter ended 2025-03 | 2025-04-16 | $10.4B | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
P/E is at percentile 99 of its 5-year rangeExpensive
5-year range 15.7 – 37.7 · Median 31.3
Last 4 quarters: $793M in buybacks + $4.2B in dividends, 2.71% of market cap combined
P/E (TTM)
39.1
P/B
3.6
P/S
3.8
Dividend Yield
1.98%
Earnings Reaction
Over the last 6 reports, the stock moved ±1.6% on average on the first trading day after, rising 4 times
Most recent +1.87%
Volatility & Correlation
1-year beta -0.39 · Correlation with S&P 500 -0.17Low beta
Annualized volatility 29% vs. 12% for the S&P 500
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 3 · $46.9MNet selling $46.9M
- 09-02MCCOY JOHN A. JR.VICE PRESIDENT AND CONTROLLERSell$0.00M27 shares · Avg price 109.54
- 08-25Ford Robert BCHAIRMAN AND CEOSell$46.2M398,832 shares · 2 trades · Avg price 115.85
- 08-11Morrone Louis H.EXECUTIVE VICE PRESIDENTSell$0.64M5,850 shares · Avg price 109.83
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2026 Q1 | 11.16 | +7.8% | 56.2% | 1.08 | 0.61 |
| FY2025 Q4 | 11.46 | +4.4% | 57.0% | 1.78 | 1.01 |
| FY2025 Q3 | 11.37 | +6.9% | 55.4% | 1.64 | 0.94 |
| FY2025 Q2 | 11.14 | +7.4% | 56.4% | 1.78 | 1.01 |
| FY2025 Q1 | 10.36 | +4.0% | 56.9% | 1.33 | 0.76 |
| FY2024 Q4 | 10.97 | +7.2% | 55.0% | 9.23 | 5.26 |
| FY2024 Q3 | 10.64 | +4.9% | 55.8% | 1.65 | 0.94 |
| FY2024 Q2 | 10.38 | +4.0% | 55.6% | 1.30 | 0.74 |
| FY2024 Q1 | 9.96 | +2.2% | 55.2% | 1.23 | 0.70 |
| FY2023 Q4 | 10.24 | +1.5% | 55.5% | 1.59 | 0.91 |
| FY2023 Q3 | 10.14 | −2.6% | 54.6% | 1.44 | 0.82 |
| FY2023 Q2 | 9.98 | −11.4% | 55.1% | 1.38 | 0.78 |
| Ticker | P/E | Revenue YoY | Gross Margin | 1M | View |
|---|---|---|---|---|---|
| ABT | 39.1 | +7.8% | 56.2% | +7.46% | Neutral |
| LLY | 50.2 | +38.6% | 83.9% | +22.51% | Bullish |
| JNJ | 41.3 | +5.9% | 68.1% | +3.20% | Bullish |
| ABBV | 81.4 | +10.2% | 74.7% | +12.73% | Bullish |
| UNH | 23.0 | +0.4% | 88.1% | +10.87% | Bullish |
| MRK | 117.2 | +5.1% | 73.5% | +2.90% | Neutral |
| TMO | 36.4 | +9.1% | — | +3.25% | Neutral |
| AMGN | 28.5 | +9.5% | 72.0% | +10.56% | Bullish |
| GILD | — | +6.8% | 81.1% | +14.51% | Neutral |